2 results match your criteria: "The First Hospital Affiliated of Shandong First Medical University (Qianfoshan Hospital)[Affiliation]"
Retraction notice to "Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage" [DNA Repair 103C (2021) 103117].
DNA Repair (Amst)
July 2022
Department of General Surgery, The First Hospital Affiliated of Shandong First Medical University (Qianfoshan Hospital), Jinan, Shandong 250014, China.
Thymoquinone sensitizes human hepatocarcinoma cells to TRAIL-induced apoptosis via oxidative DNA damage.
DNA Repair (Amst)
July 2021
Department of General Surgery, the First Hospital Affiliated of Shandong First Medical University (Qianfoshan Hospital), Jinan, Shandong, 250014, China. Electronic address:
Introduction: Hepatocellular carcinoma (HCC) remains one of the most predominant types of digestive system malignancies worldwide. TNF-related apoptosis-inducing ligand (TRAIL) is a biological cytokine with the mentioned specificity, but some tumor cells' resistance limits its use as a therapeutic approach. The present study aimed to investigate thymoquinone (TQ) and TRAIL's combined effect and the potential mechanisms in human hepatic HepG2 carcinoma cells.
View Article and Find Full Text PDF